Target intelligence / Profile preview

Multiple fungal proteins and membranes

Molecular classification
Other
01

Overview

The term Multiple fungal proteins and membranes refers to a broad set of molecular structures and biosynthetic pathways essential for the survival and structural integrity of fungal pathogens. Key components include the fungal cell membrane, where the sterol ergosterol provides stability and is a primary target for polyene antibiotics like Amphotericin B [1]. Another critical component is the fungal cell wall, composed of chitin and beta-glucans, which is targeted by echinocandins to cause cell lysis [2]. This collective target also includes vital enzymes such as lanosterol 14-alpha demethylase (CYP51), which is inhibited by azole antifungals to prevent ergosterol synthesis [3]. Furthermore, it encompasses intracellular targets like those involved in nucleic acid synthesis, which are disrupted by agents such as flucytosine [5]. These targets are essential for maintaining the osmotic balance and protective barrier of the fungus against the host environment [4]. Drugs acting on these multiple sites are used to treat a variety of infections, including invasive candidiasis and aspergillosis [1, 3]. However, the complexity of these targets and their occasional similarity to human cellular components can lead to significant side effects, such as nephrotoxicity, hepatotoxicity, and drug-drug interactions [1, 3, 5].

Other names
Fungal cell componentsFungal membrane and cell wall targetsBroad-spectrum fungal targets
02

Mechanism of action

Inhibition of ergosterol synthesis, direct membrane pore formation, inhibition of cell wall beta-glucan synthesis, and interference with nucleic acid synthesis.

03

Biological functions

Cell wall synthesisMembrane integrityErgosterol biosynthesisNucleic acid synthesisFungal growth and replication
04

Disease associations

InfectionCandidiasisAspergillosisCryptococcosisMycosis
05

Safety considerations

NephrotoxicityHepatotoxicityInfusion-related reactionsDrug-drug interactions via CYP450 inhibitionBone marrow suppression
06

Interacting drugs

Amphotericin B

6 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucanGalactomannanErgosterol levels

Beyond the preview

Go deeper on Multiple fungal proteins and membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple fungal proteins and membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call